Whilst fetal overgrowth in maternal obesity and diabetes is commonly associated with placentomegaly, it is also possible that the resulting hPL excess may further stimulate both maternal and fetal beta-cell expansion and increase fetal insulin production, which would promote glycogenesis, fat deposition and fetal growth [9]. Here, INS is linked to diabetes mellitus.